medigraphic.com
SPANISH

Revista de Endocrinología y Nutrición

ISSN 0188-9796 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2003, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2003; 11 (2)

How to prepare visual deficiency in patients with diabetic retinopathy?

Lima GV
Full text How to cite this article

Language: Spanish
References: 17
Page: 55-60
PDF size: 74.78 Kb.


Key words:

Detection, diabetes, diabetic retinopathy, visual deficiency..

ABSTRACT

Background: Timely detection and proper grading of diabetic retinopathy reduce visual deficiency. Aim: To identify the rate of diabetic patients with retinopathy in whom visual deficiency could be prevented. Method: Records of patients evaluated during retinopathy detection campaigns were reviewed, and the rate of retinopathy, non-proliferative retinopathy, proliferative retinopathy, macular edema and vitreous hemorrhage were identified. The most affected eye’s grade was considered when retinopathy was asymmetrical. The rate of patients with unfavorable prognosis and in those in which treatment could prevent visual deficiency were identified. Results: Three hundred and nine of 1,840 patients had retinopathy (non-proliferative 282, 91.3%, proliferative 27, 8.7%). Thirty four patients had macular edema (11%) and 9 vitreous hemorrhage (2.9%). Thirty patients with non-proliferative retinopathy had visual deficiency, 4 had an unfavorable prognosis (1.4%), 21 patients with proliferative retinopathy had visual deficiency, 8 had an unfavorable prognosis (29.6%). Discussion: Nine patients with diabetic retinopathy had visual deficiency and would have an unfavorable prognosis despite treatment. In 98.6% of patients with non-proliferative retinopathy and in 70.4% of those with proliferative retinopathy, visual deficiency could have been prevented. Finding diabetic retinopathy should encourage establishing an adequate systemic and ophthalmic therapy, even in patients with proliferative retinopathy, in order to reduce the incidence of visual deficiency.


REFERENCES

  1. Fong DS, Aiello L, Gardner TW et al. Diabetic Retinopathy. American Diabetes Association. Position Statement. Diabetes Care 2003; 26: S99-102.

  2. American Academy of Ophthalmology. Basic and Clinical Science Course. Section 12. Retina and Vitreous. San Francisco, The Foundation of the American Academy of Ophthalmology. 2000.

  3. González-Villalpando C, González VME, Rivera MD, Stern MP. Incidencia y progresión de la retinopatía diabética en una población de escasos recursos en la ciudad de México. Rev Invest Clin 1999; 51: 141-150.

  4. Lima GV. Oportunidad de detección temprana de retinopatía diabética mediante campañas de evaluación masiva. Rev Hosp Jua Mex 2000; 68: 4-7.

  5. Lima GV, Rojas DJA. Estrategia de detección masiva de retinopatía diabética. El día “D” en el Hospital Juárez de México. Cir Ciruj 2000; 68: 63-67.

  6. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984; 91: 1-8.

  7. Lima G, Mora PE. Causas de deficiencia visual en pacientes diabéticos mexicanos. Revista de Endocrinología y Nutrición 2001; 9: 176-180.

  8. Cano VO. Oftalmología Legal. México, Prado Editores, 2003.

  9. Albert DM, Jakobiec FA. Principles and Practice of Ophthalmology. Philadelphia, WB Saunders Co. 1994. C.D.

  10. Simons K. Visual acuity and the functional definition of blindness. In: Tasman & Jaeger (eds). Duane’s Clinical Ophthalmology. Philadelphia, Lippincott Williams and Wilkins, 1998; 5(51): 1.

  11. Begg IS, Schulzer M. Eye disease. In: Evidence-based diabetes care. Hamilton, BC Decker 2001: 396-428.

  12. Mukamel DB, Bresnick GH, Wang Q, Dickey CF. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 1999; 6: 61-72.

  13. Lima GV, De León OJ, Duarte TM, Rojas DJA. Retinopatía en pacientes diabéticos tratados por diferentes especialistas. Reporte preliminar. Rev Fac Med UNAM 2001; 3: 109-112.

  14. González VME, Arredondo PB, González VC. Retinopatía diabética: prevalencia y severidad. Registro Hospital Central Sur PEMEX. Rev Mex Oftalmol 1994; 68: 61-66.

  15. Philips M, Del Río I, Quiroz H. Oportunidades de reducir los costos del tratamiento de la retinopatía diabética en México. Boletin of Sanit Panam 1994; 117: 22-32.

  16. Hansson-Lundblad C, Holm K, Agardh CD, Agardh E. A small number of older type 2 diabetic patients end up visually impaired despite regular photographic screening and laser treatment for diabetic retinopathy. Acta Ophthalmol Scand 2002; 80: 310-315.

  17. Porta M, Bandello F. Diabetic retinopathy. A clinical update. Diabetologia 2002; 45: 1617-34.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Endocrinol Nutr. 2003;11